{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:32:40Z","timestamp":1740105160701,"version":"3.37.3"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031028","name":"Rajavithi Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006691","name":"Harvard Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ahj.2024.11.015","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T16:58:01Z","timestamp":1733245081000},"page":"84-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Primary medication adherence in Medicare beneficiaries prescribed sacubitril-valsartan or renin-angiotensin system blockers for heart failure with reduced ejection fraction"],"prefix":"10.1016","volume":"281","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0185-3256","authenticated-orcid":false,"given":"Catherine S.","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi J.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron S.","family":"Kesselheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raisa","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin N.","family":"Rome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2024.11.015_bib0001","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s40273-020-00952-0","article-title":"A systematic review of medical costs associated with heart failure in the USA (2014-2020)","volume":"38","author":"Urbich","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ahj.2024.11.015_bib0002","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022164","article-title":"Out-of-pocket annual health expenditures and financial toxicity from healthcare costs in patients with heart failure in the United States","volume":"10","author":"Wang","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2024.11.015_bib0003","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2024.11.015_bib0004","first-page":"e240","volume":"128","author":"CW","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2024.11.015_bib0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11886-020-01352-8","article-title":"Should angiotensin-converting enzyme inhibitors ever be used for the management of hypertension?","volume":"22","author":"Turner","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.ahj.2024.11.015_bib0006","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s11606-020-06214-1","article-title":"The ecology of antihypertensives in the United States, 1997-2017","volume":"36","author":"Johansen","year":"2021","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ahj.2024.11.015_bib0007","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1524-6175.2002.01510.x","article-title":"Eplerenone: a new aldosterone receptor antagonist\u2013are the FDA\u2019s restrictions appropriate?","volume":"4","author":"Sica","year":"2002","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.ahj.2024.11.015_bib0008","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2024.11.015_bib0009","unstructured":"United States Food and Drug Administration, ENTRESTO\u00ae (sacubitril and valsartan) tablets. 2015. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/207620s018lbl.pdf Accessed December 18, 2024."},{"key":"10.1016\/j.ahj.2024.11.015_bib0010","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2024.11.015_bib0011","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/jamacardio.2023.3216","article-title":"Health and economic evaluation of sacubitril-valsartan for heart failure management","volume":"8","author":"Bhatt","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ahj.2024.11.015_bib0012","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023950","article-title":"Use and out-of-pocket cost of sacubitril-valsartan in patients with heart failure","volume":"11","author":"Shore","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2024.11.015_bib0013","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1001\/archinternmed.2009.62","article-title":"Cost sharing and the initiation of drug therapy for the chronically ill","volume":"169","author":"Solomon","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2024.11.015_bib0014","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.socscimed.2005.06.045","article-title":"A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures","volume":"62","author":"Piette","year":"2006","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.ahj.2024.11.015_bib0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.298.1.61","article-title":"Prescription drug cost sharing: associations with medication and medical utilization and spending and health","volume":"298","author":"Goldman","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2024.11.015_bib0016","doi-asserted-by":"crossref","first-page":"441","DOI":"10.7326\/M13-1705","article-title":"The incidence and determinants of primary nonadherence with prescribed medication in primary care: a cohort study","volume":"160","author":"Tamblyn","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2024.11.015_bib0017","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2008.03.045","article-title":"One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic","volume":"59","author":"Storm","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ahj.2024.11.015_bib0018","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11606-010-1253-9","article-title":"Primary medication non-adherence: analysis of 195,930 electronic prescriptions","volume":"25","author":"Fischer","year":"2010","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ahj.2024.11.015_bib0019","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.amjmed.2011.05.028","article-title":"Trouble getting started: predictors of primary medication nonadherence","volume":"124","author":"Fischer","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2024.11.015_bib0020","first-page":"1044","article-title":"Calculating the benefits of a research patient data repository","volume":"2006","author":"Nalichowski","year":"2006","journal-title":"AMIA Annu Symp Proc"},{"key":"10.1016\/j.ahj.2024.11.015_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006814","article-title":"Prediction score for anticoagulation control quality among older adults","volume":"6","author":"Lin","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2024.11.015_bib0022","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/CLEP.S397020","article-title":"A novel chronic kidney disease phenotyping algorithm using combined electronic health record and claims data","volume":"15","author":"Mansour","year":"2023","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ahj.2024.11.015_bib0023","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004873","article-title":"National burden of heart failure events in the United States, 2006 to 2014","volume":"11","author":"Jackson","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2024.11.015_bib0024","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004700","article-title":"Development and preliminary validation of a Medicare claims-based model to predict left ventricular ejection fraction class in patients with heart failure","volume":"11","author":"Desai","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2024.11.015_bib0025","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004302","article-title":"Adoption of sacubitril-valsartan for the management of patients with heart failure","volume":"11","author":"Sangaralingham","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2024.11.015_bib0026","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/ejhf.2572","article-title":"Sacubitril-valsartan use patterns among older adults with heart failure in clinical practice: a population-based cohort study of >25\u2009000 Medicare beneficiaries","volume":"24","author":"Bhatt","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2024.11.015_bib0027","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/ggi.12616","article-title":"Systematic review of the barriers affecting medication adherence in older adults","volume":"16","author":"Yap","year":"2016","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.ahj.2024.11.015_bib0028","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5001\/omj.2011.38","article-title":"Patient medication adherence: measures in daily practice","volume":"26","author":"Jimmy","year":"2011","journal-title":"Oman Med J"},{"key":"10.1016\/j.ahj.2024.11.015_bib0029","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.amjopharm.2011.02.004","article-title":"A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity","volume":"9","author":"Gellad","year":"2011","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.ahj.2024.11.015_bib0030","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/her\/cyu023","article-title":"A matter of trust: patient barriers to primary medication adherence","volume":"29","author":"Polinski","year":"2014","journal-title":"Health Educ Res"},{"key":"10.1016\/j.ahj.2024.11.015_bib0031","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.007665","article-title":"Prior authorization, copayments, and utilization of Sacubitril-valsartan in medicare and commercial plans in patients with heart failure with reduced ejection fraction","volume":"14","author":"Ozaki","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2024.11.015_bib0032","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijcard.2016.04.082","article-title":"Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: a meta-regression analysis","volume":"216","author":"Weeda","year":"2016","journal-title":"Int J Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870324003168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870324003168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T13:11:29Z","timestamp":1739020289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870324003168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":32,"alternative-id":["S0002870324003168"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2024.11.015","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary medication adherence in Medicare beneficiaries prescribed sacubitril-valsartan or renin-angiotensin system blockers for heart failure with reduced ejection fraction","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2024.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}